Approvals/TGA/Fluzone Inactivated Trivalent Influenza Vaccine (Split Virion)-Influenza virus haemagglutinin, 45 mcg/ 0.5 mL suspension for injection, syringe

Approved

STANDARD

Fluzone Inactivated Trivalent Influenza Vaccine (Split Virion)-Influenza virus haemagglutinin, 45 mcg/ 0.5 mL suspension for injection, syringe

Sanofi-Aventis Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Date: May 30, 2025
Approval ID: a483f4c911257079
Company: Sanofi-Aventis Australia Pty Ltd
Type: Standard

Approval Details

Approval Id: a483f4c911257079
Product Name: Fluzone Inactivated Trivalent Influenza Vaccine (Split Virion)-Influenza virus haemagglutinin, 45 mcg/ 0.5 mL suspension for injection, syringe
Artg Id: 446170
Artg Name: Fluzone Inactivated Trivalent Influenza Vaccine (Split Virion) - Influenza virus haemagglutinin, 45 mcg/ 0.5 mL, suspension for injection, syringe
Sponsor: Sanofi-Aventis Australia Pty Ltd
Company Detail Path: /organization/sanofi-aventis-australia-pty-ltd
Artg Date: 2025-05-09
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/c348ef7958c00fc3a328a7c14e903a61.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/1184d764e86713efb80ff3d22ca9d7cf.pdf

Active Ingredients

Approved

Quick Info

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

a483f4c911257079

Type

Standard

Back to TGA Approvals